Literature DB >> 31201689

Non-alcoholic fatty liver disease and coronary atherosclerosis-does myocardial glucose metabolism provide the missing link?

S M Clifford1, D J Murphy2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31201689     DOI： 10.1007/s12350-019-01783-z

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  18 in total

Review 1.  NAFLD: a multisystem disease.

Authors:  Christopher D Byrne; Giovanni Targher
Journal:  J Hepatol       Date:  2015-04       Impact factor: 25.083

Review 2.  The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.

Authors:  Naga Chalasani; Zobair Younossi; Joel E Lavine; Michael Charlton; Kenneth Cusi; Mary Rinella; Stephen A Harrison; Elizabeth M Brunt; Arun J Sanyal
Journal:  Hepatology       Date:  2017-09-29       Impact factor: 17.425

Review 3.  Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.

Authors:  Leon A Adams; Quentin M Anstee; Herbert Tilg; Giovanni Targher
Journal:  Gut       Date:  2017-03-17       Impact factor: 23.059

4.  Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease.

Authors:  Janus P Ong; Angela Pitts; Zobair M Younossi
Journal:  J Hepatol       Date:  2008-07-09       Impact factor: 25.083

Review 5.  Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

Authors:  Zobair M Younossi; Aaron B Koenig; Dinan Abdelatif; Yousef Fazel; Linda Henry; Mark Wymer
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425

Review 6.  Nonalcoholic fatty liver disease and vascular disease: state-of-the-art.

Authors:  Silvia Fargion; Marianna Porzio; Anna Ludovica Fracanzani
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

7.  Natural history of hepatic steatosis: observed outcomes for subsequent liver and cardiovascular complications.

Authors:  Perry J Pickhardt; Luke Hahn; Alejandro Muñoz del Rio; Seong Ho Park; Scott B Reeder; Adnan Said
Journal:  AJR Am J Roentgenol       Date:  2014-04       Impact factor: 3.959

8.  Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis.

Authors:  Giovanni Targher; Christopher D Byrne; Amedeo Lonardo; Giacomo Zoppini; Corrado Barbui
Journal:  J Hepatol       Date:  2016-05-17       Impact factor: 25.083

Review 9.  Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis.

Authors:  Shunquan Wu; Fuquan Wu; Yingying Ding; Jun Hou; Jingfeng Bi; Zheng Zhang
Journal:  Sci Rep       Date:  2016-09-16       Impact factor: 4.379

Review 10.  Nonalcoholic fatty liver disease - A multisystem disease?

Authors:  Ivana Mikolasevic; Sandra Milic; Tamara Turk Wensveen; Ivana Grgic; Ivan Jakopcic; Davor Stimac; Felix Wensveen; Lidija Orlic
Journal:  World J Gastroenterol       Date:  2016-11-21       Impact factor: 5.742
View more
  1 in total

1.  Hepatic steatosis is associated with abnormal hepatic enzymes, visceral adiposity, altered myocardial glucose uptake measured by 18F-FDG PET/CT.

Authors:  Lijun Hu; Xiaoliang Shao; Chun Qiu; Xiaonan Shao; Xiaosong Wang; Rong Niu; Yuetao Wang
Journal:  BMC Endocr Disord       Date:  2020-05-27       Impact factor: 2.763
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.